VIMTA LABS
Back to Income Statement
|
VIMTA LABS Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹41 Cr | ₹48 Cr | ₹41 Cr | ₹21 Cr | ₹6.85 Cr |
What is the latest Consolidated Net Profit of VIMTA LABS ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹41 Cr |
Mar2023 | ₹48 Cr |
Mar2022 | ₹41 Cr |
Mar2021 | ₹21 Cr |
Mar2020 | ₹6.85 Cr |
How is Consolidated Net Profit of VIMTA LABS Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹41 Cr | -14.87 | |
Mar2023 | ₹48 Cr | 16.55 | |
Mar2022 | ₹41 Cr | 93.09 | |
Mar2021 | ₹21 Cr | 212.71 | |
Mar2020 | ₹6.85 Cr | - |
Compare Consolidated Net Profit of peers of VIMTA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VIMTA LABS | ₹3,056.0 Cr | -0.9% | -16.7% | 147.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,560.0 Cr | 2.2% | 2.1% | -10.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,033.0 Cr | 0.3% | 6.4% | 8.7% | Stock Analytics | |
CIPLA | ₹134,400.0 Cr | 6.8% | 5.6% | 5.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,507.0 Cr | 1.6% | -1.1% | 5.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,628.0 Cr | 4.6% | -2.5% | -4.3% | Stock Analytics |
VIMTA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VIMTA LABS | -0.9% |
-16.7% |
147.9% |
SENSEX | 2.9% |
1.7% |
3.6% |
You may also like the below Video Courses